▶ 調査レポート

タシグナの世界市場2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Tasigna Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。タシグナの世界市場2020年:メーカー別、地域別、種類・用途別 / Global Tasigna Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / MRC2012A9911資料のイメージです。• レポートコード:MRC2012A9911
• 出版社/出版日:GlobalInfoResearch / 2020年12月28日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、103ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医薬品、医療
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、タシグナの世界市場を広く調査・分析し、今後の市場展望をまとめております。タシグナの種類別市場規模(50mg、200mg、その他)、用途別市場規模(病院、ドラッグストア、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Novartis、
・地域別グローバル市場分析 2015年-2020年
・タシグナの北米市場(アメリカ、カナダ、メキシコ)
・タシグナのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・タシグナのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・タシグナの南米市場(ブラジル、アルゼンチン)
・タシグナの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:50mg、200mg、その他
・用途別分析:病院、ドラッグストア、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Tasigna market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Tasigna market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Tasigna market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Tasigna market has been segmented into
50mg
200mg
Other

By Application, Tasigna has been segmented into:
Hospital
Drugs Store
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Tasigna market presented in the report. This section sheds light on the sales growth of different regional and country-level Tasigna markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Tasigna market.

The report offers in-depth assessment of the growth and other aspects of the Tasigna market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Tasigna Market Share Analysis
Tasigna competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Tasigna sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Tasigna sales, revenue and market share for each player covered in this report.

The major players covered in Tasigna are:
Novartis

Among other players domestic and global, Tasigna market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tasigna product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tasigna, with price, sales, revenue and global market share of Tasigna in 2018 and 2019.
Chapter 3, the Tasigna competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tasigna breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Tasigna market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Tasigna sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Tasigna Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Tasigna Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 50mg
1.2.3 200mg
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Tasigna Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Overview of Global Tasigna Market
1.4.1 Global Tasigna Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Tasigna Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Tasigna Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Tasigna Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Tasigna Manufacturer Market Share in 2019
3.3.2 Top 6 Tasigna Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Tasigna Sales, Revenue and Market Share by Regions
4.1.1 Global Tasigna Sales and Market Share by Regions (2015-2020)
4.1.2 Global Tasigna Revenue and Market Share by Regions (2015-2020)
4.2 North America Tasigna Sales and Growth Rate (2015-2020)
4.3 Europe Tasigna Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Tasigna Sales and Growth Rate (2015-2020)
4.5 South America Tasigna Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Tasigna Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Tasigna Sales, Revenue and Market Share by Country
5.1.1 North America Tasigna Sales and Market Share by Country (2015-2020)
5.1.2 North America Tasigna Revenue and Market Share by Country (2015-2020)
5.2 United States Tasigna Sales and Growth Rate (2015-2020)
5.3 Canada Tasigna Sales and Growth Rate (2015-2020)
5.4 Mexico Tasigna Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Tasigna Sales, Revenue and Market Share by Country
6.1.1 Europe Tasigna Sales and Market Share by Country (2015-2020)
6.1.2 Europe Tasigna Revenue and Market Share by Country (2015-2020)
6.2 Germany Tasigna Sales and Growth Rate (2015-2020)
6.3 UK Tasigna Sales and Growth Rate (2015-2020)
6.4 France Tasigna Sales and Growth Rate (2015-2020)
6.5 Russia Tasigna Sales and Growth Rate (2015-2020)
6.6 Italy Tasigna Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Tasigna Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Tasigna Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Tasigna Revenue and Market Share by Regions (2015-2020)
7.2 China Tasigna Sales and Growth Rate (2015-2020)
7.3 Japan Tasigna Sales and Growth Rate (2015-2020)
7.4 Korea Tasigna Sales and Growth Rate (2015-2020)
7.5 India Tasigna Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Tasigna Sales and Growth Rate (2015-2020)
7.7 Australia Tasigna Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Tasigna Sales, Revenue and Market Share by Country
8.1.1 South America Tasigna Sales and Market Share by Country (2015-2020)
8.1.2 South America Tasigna Revenue and Market Share by Country (2015-2020)
8.2 Brazil Tasigna Sales and Growth Rate (2015-2020)
8.3 Argentina Tasigna Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Tasigna Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Tasigna Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Tasigna Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Tasigna Sales and Growth Rate (2015-2020)
9.3 Turkey Tasigna Sales and Growth Rate (2015-2020)
9.4 Egypt Tasigna Sales and Growth Rate (2015-2020)
9.5 South Africa Tasigna Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Tasigna Sales and Market Share by Type (2015-2020)
10.2 Global Tasigna Revenue and Market Share by Type (2015-2020)
10.3 Global Tasigna Price by Type (2015-2020)
11 Global Tasigna Market Segment by Application
11.1 Global Tasigna Sales Market Share by Application (2015-2020)
11.2 Global Tasigna Revenue Market Share by Application (2015-2020)
11.3 Global Tasigna Price by Application (2015-2020)
12 Market Forecast
12.1 Global Tasigna Sales, Revenue and Growth Rate (2021-2025)
12.2 Tasigna Market Forecast by Regions (2021-2025)
12.2.1 North America Tasigna Market Forecast (2021-2025)
12.2.2 Europe Tasigna Market Forecast (2021-2025)
12.2.3 Asia-Pacific Tasigna Market Forecast (2021-2025)
12.2.4 South America Tasigna Market Forecast (2021-2025)
12.2.5 Middle East & Africa Tasigna Market Forecast (2021-2025)
12.3 Tasigna Market Forecast by Type (2021-2025)
12.3.1 Global Tasigna Sales Forecast by Type (2021-2025)
12.3.2 Global Tasigna Market Share Forecast by Type (2021-2025)
12.4 Tasigna Market Forecast by Application (2021-2025)
12.4.1 Global Tasigna Sales Forecast by Application (2021-2025)
12.4.2 Global Tasigna Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Tasigna Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Tasigna by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Tasigna Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Tasigna Major Business
Table 9. Novartis Tasigna Total Revenue (USD Million) (2017-2018)
Table 10. Novartis SWOT Analysis
Table 11. Novartis Tasigna Product and Services
Table 12. Novartis Tasigna Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Global Tasigna Sales by Manufacturer (2018-2019) (MT)
Table 14. Global Tasigna Revenue by Manufacturer (2018-2019) (USD Million)
Table 15. Global Tasigna Sales by Regions (2015-2020) (MT)
Table 16. Global Tasigna Sales Market Share by Regions (2015-2020)
Table 17. Global Tasigna Revenue by Regions (2015-2020) (USD Million)
Table 18. North America Tasigna Sales by Countries (2015-2020) (MT)
Table 19. North America Tasigna Sales Market Share by Countries (2015-2020)
Table 20. North America Tasigna Revenue by Countries (2015-2020) (USD Million)
Table 21. North America Tasigna Revenue Market Share by Countries (2015-2020)
Table 22. Europe Tasigna Sales by Countries (2015-2020) (MT)
Table 23. Europe Tasigna Sales Market Share by Countries (2015-2020)
Table 24. Europe Tasigna Revenue by Countries (2015-2020) (USD Million)
Table 25. Asia-Pacific Tasigna Sales by Regions (2015-2020) (MT)
Table 26. Asia-Pacific Tasigna Sales Market Share by Regions (2015-2020)
Table 27. Asia-Pacific Tasigna Revenue by Regions (2015-2020) (USD Million)
Table 28. South America Tasigna Sales by Countries (2015-2020) (MT)
Table 29. South America Tasigna Sales Market Share by Countries (2015-2020)
Table 30. South America Tasigna Revenue by Countries (2015-2020) (USD Million)
Table 31. South America Tasigna Revenue Market Share by Countries (2015-2020)
Table 32. Middle East & Africa Tasigna Sales by Countries (2015-2020) (MT)
Table 33. Middle East & Africa Tasigna Sales Market Share by Countries (2015-2020)
Table 34. Middle East & Africa Tasigna Revenue by Countries (2015-2020) (USD Million)
Table 35. Middle East & Africa Tasigna Revenue Market Share by Countries (2015-2020)
Table 36. Global Tasigna Sales by Type (2015-2020) (MT)
Table 37. Global Tasigna Sales Share by Type (2015-2020)
Table 38. Global Tasigna Revenue by Type (2015-2020) (USD Million)
Table 39. Global Tasigna Revenue Share by Type (2015-2020)
Table 40. Global Tasigna Sales by Application (2015-2020) (MT)
Table 41. Global Tasigna Sales Share by Application (2015-2020)
Table 42. Global Tasigna Sales Forecast by Regions (2021-2025) (MT)
Table 43. Global Tasigna Market Share Forecast by Regions (2021-2025)
Table 44. Global Tasigna Sales Forecast by Type (2021-2025) (MT)
Table 45. Global Tasigna Market Share Forecast by Type (2021-2025)
Table 46. Global Tasigna Sales Forecast by Application (2021-2025)
Table 47. Global Tasigna Market Share Forecast by Application (2021-2025)
Table 48. Direct Channel Pros & Cons
Table 49. Indirect Channel Pros & Cons
Table 50. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Tasigna Picture
Figure 2. Global Sales Market Share of Tasigna by Type in 2019
Figure 3. 50mg Picture
Figure 4. 200mg Picture
Figure 5. Other Picture
Figure 6. Tasigna Sales Market Share by Application in 2018
Figure 7. Hospital Picture
Figure 8. Drugs Store Picture
Figure 9. Other Picture
Figure 10. Global Tasigna Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Tasigna Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Tasigna Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Tasigna Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Tasigna Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Tasigna Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Tasigna Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Tasigna Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Tasigna Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Tasigna Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Tasigna Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Tasigna Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Tasigna Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Tasigna Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Tasigna Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Tasigna Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Tasigna Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Tasigna Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Tasigna Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Tasigna Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Tasigna Sales Market Share by Manufacturer in 2019
Figure 31. Global Tasigna Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Tasigna Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Tasigna Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Tasigna Sales and Growth Rate (2015-2020) (MT)
Figure 36. Global Tasigna Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Tasigna Revenue Market Share by Regions (2015-2020)
Figure 38. Global Tasigna Revenue Market Share by Regions in 2018
Figure 39. North America Tasigna Sales and Growth Rate (2015-2020)
Figure 40. Europe Tasigna Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Tasigna Sales and Growth Rate (2015-2020)
Figure 42. South America Tasigna Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Tasigna Sales and Growth Rate (2015-2020)
Figure 44. North America Tasigna Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Tasigna Sales Market Share by Countries (2015-2020)
Figure 46. North America Tasigna Sales Market Share by Countries in 2018
Figure 47. North America Tasigna Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Tasigna Revenue Market Share by Countries in 2018
Figure 49. United States Tasigna Sales and Growth Rate (2015-2020) (MT)
Figure 50. Canada Tasigna Sales and Growth Rate (2015-2020) (MT)
Figure 51. Mexico Tasigna Sales and Growth Rate (2015-2020) (MT)
Figure 52. Europe Tasigna Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Tasigna Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Tasigna Revenue Market Share by Countries in 2019
Figure 55. Germany Tasigna Sales and Growth Rate (2015-2020) (MT)
Figure 56. UK Tasigna Sales and Growth Rate (2015-2020) (MT)
Figure 57. France Tasigna Sales and Growth Rate (2015-2020) (MT)
Figure 58. Russia Tasigna Sales and Growth Rate (2015-2020) (MT)
Figure 59. Italy Tasigna Sales and Growth Rate (2015-2020) (MT)
Figure 60. Asia-Pacific Tasigna Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Tasigna Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Tasigna Revenue Market Share by Regions 2019
Figure 63. China Tasigna Sales and Growth Rate (2015-2020) (MT)
Figure 64. Japan Tasigna Sales and Growth Rate (2015-2020) (MT)
Figure 65. Korea Tasigna Sales and Growth Rate (2015-2020) (MT)
Figure 66. India Tasigna Sales and Growth Rate (2015-2020) (MT)
Figure 67. Southeast Asia Tasigna Sales and Growth Rate (2015-2020) (MT)
Figure 68. South America Tasigna Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Tasigna Sales Market Share by Countries in 2019
Figure 70. South America Tasigna Revenue Market Share by Countries in 2019
Figure 71. Brazil Tasigna Sales and Growth Rate (2015-2020) (MT)
Figure 72. Argentina Tasigna Sales and Growth Rate (2015-2020) (MT)
Figure 73. Middle East and Africa Tasigna Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Tasigna Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Tasigna Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Tasigna Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Tasigna Sales and Growth Rate (2015-2020) (MT)
Figure 78. Egypt Tasigna Sales and Growth Rate (2015-2020) (MT)
Figure 79. Turkey Tasigna Sales and Growth Rate (2015-2020) (MT)
Figure 80. South Africa Tasigna Sales and Growth Rate (2015-2020) (MT)
Figure 81. Global Tasigna Sales and Growth Rate (2021-2025) (MT)
Figure 82. Global Tasigna Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Tasigna Market Forecast (2021-2025) (MT)
Figure 84. Europe Sales Tasigna Market Forecast (2021-2025) (MT)
Figure 85. Asia-Pacific Sales Tasigna Market Forecast (2021-2025) (MT)
Figure 86. South America Sales Tasigna Market Forecast (2021-2025) (MT)
Figure 87. Middle East & Africa Sales Tasigna Market Forecast (2021-2025) (MT)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel